Spectral Medical IncOTC Pink - Current Information:EDTXFView on Canadian Exchange
- LAST PRICE0.2400
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.2400 / 0.2400
- Day Range
- 52 Week Range
- Volume25,000
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | EDTXF |
|---|---|---|
| 09:32 ET | 25000 | 0.24 |
Jan 12, 2023
Spectral Medical Providing Update on Tigris Clinical Trial and Other Business Developments, from 8:21AM ET on Thursday Jan 12, 2023 by MT Newswires
8:21AM ET on Thursday Jan 12, 2023 by MT NewswiresBRIEF-Spectral Medical Provides Update On Tigris Clinical Trial And Other Business Developments, from 7:37AM ET on Thursday Jan 12, 2023 by Thomson Reuters
7:37AM ET on Thursday Jan 12, 2023 by Thomson Reuters-- Spectral Medical Brief: Providing Update on Tigris Clinical Trial and Other Business Developments, from 7:35AM ET on Thursday Jan 12, 2023 by MT Newswires
7:35AM ET on Thursday Jan 12, 2023 by MT NewswiresSpectral Medical Provides Update on Tigris Clinical Trial and Other Business Developments, from 7:30AM ET on Thursday Jan 12, 2023 by GlobeNewswire
7:30AM ET on Thursday Jan 12, 2023 by GlobeNewswire
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Spectral Medical Inc | 90.5M | -7.6x | --- |
Odonate Therapeutics Inc | 52.7M | -0.7x | --- |
PharmaCyte Biotech Inc | 55.6M | -11.0x | --- |
Global Pharmatech Inc | 55.3M | -2.1x | --- |
Equillium Inc | 39.8M | -0.5x | --- |
ASP Isotopes Inc | 62.5M | 0.0x | --- |
Company Information
Spectral Medical Inc. is a Canada-based company that develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company's EAA. It is engaged in the development of biochemical markers for the clinical syndrome known as septic shock. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development as well as in products manufactured by other diagnostic companies. The Company through its wholly owned subsidiary, Dialco Medical Inc., is also commercializing a set of platforms addressing renal replacement therapy (RRT) across the dialysis spectrum. Its dialysis machine, SAMI is targeting the acute RRT market, while its home hemodialysis machine, DIMI is targeting the chronic RRT market.
Contact Information
- Headquarters
- 135 The West Mall, Unit 2TORONTO, ON, Canada M9C 1C2
- Phone
- 416-626-3233
- Fax
- 416-626-3233
Executives
- Non-Executive Independent Chairman of the Board
- Anthony Bihl
- President, Director
- Paul Walker
- Chief Executive Officer
- Chris Seto
- Chief Financial Officer
- Blair Mcinnis
- Chief Medical Officer
- John Kellum
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $68.0M |
|---|---|
Revenue (TTM) | $1.2M |
Shares Outstanding | 278.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.70 |
EPS | $-0.03 |
Book Value | $0.01 |
P/E Ratio | -7.6x |
Price/Sales (TTM) | 54.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -682.12% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
